Rituxan Hycela
Active Ingredient(s): Hyaluronidase + RituximabFDA Approved: * June 22, 2017
Pharm Company: * GENENTECH INC
Category: Cancer
Rituximab, sold under the brand name Rituxan among others, is a monoclonal antibody medication used to treat certain autoimmune diseases and types of cancer.[9] It is used for non-Hodgkin lymphoma, chronic lymphocytic leukemia (in non-geriatric patients), rheumatoid arthritis, granulomatosis with polyangiitis, idiopathic thrombocytopenic purpura, pemphigus vulgaris, myasthenia gravis and Epstein–Barr virus-positive mucocutaneous ulcers.[9][10&... [wikipedia]
* May have multiple approval dates, manufacturers, or labelers.